Calcitonin therapy in osteoporotic syndromes.
Since its introduction in 1961, calcitonin has effectively been used to reverse bone loss observed in paraplegic patients, atrophy of bone, and other disorders. This article focuses on the effect of calcitonin therapy in the treatment of osteoporosis.
Avioli
L V
LV
Washington University School of Medicine, St. Louis, Missouri.
D000368:Aged; D016723:Bone Remodeling / Q000187:drug effects; D002116:Calcitonin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000503:physiopathology / Q000517:prevention & control*; D015663:Osteoporosis, Postmenopausal / Q000503:physiopathology / Q000517:prevention & control; D016103:Spinal Fractures / Q000517:prevention & control
D002116:Calcitonin